Kabi: US Pegfilgrastim Crowd Is An Opportunity For Us, Not A Deterrent

‘We’ve Seen Some Missteps In Supply,’ Kabi Exec Tells Generics Bulletin

 
• By Dean Rudge
  
Elnur/Shutterstock.com
• Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products